Skip to content

Clinical trials

Expanded access Recurrence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Expanded access Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available17
Approved for marketing11
Available6
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC3
Kite, A Gilead Company2
Pfizer2
Regeneron Pharmaceuticals2
ADC Therapeutics S.A.1
Amgen1
Avobis Bio, LLC1
Barbara Ann Karmanos Cancer Institute1
BeiGene1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence35
Multiple Myeloma10
Neoplasms5
Lymphoma, Large B-Cell, Diffuse4
Lymphoma3
Lymphoma, Mantle-Cell3
Neuroblastoma3
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Acute2

Trials

Showing 51 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.